PROM1 and neoplasm: In addition, we importantly found a full decrease in the expression of CD133 CSC marker induced by pathological permanent magnetically-mimicked tumor growth pressure, following Vande treatment (Fig. 4a, d and Supplementary Fig. 11a, c).